105 related articles for article (PubMed ID: 21552018)
1. Value of dual-time-point FDG PET/CT for mediastinal nodal staging in non-small-cell lung cancer patients with lung comorbidity.
Hu M; Han A; Xing L; Yang W; Fu Z; Huang C; Zhang P; Kong L; Yu J
Clin Nucl Med; 2011 Jun; 36(6):429-33. PubMed ID: 21552018
[TBL] [Abstract][Full Text] [Related]
2. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
3. Impact of dual-time-point F-18 FDG PET/CT in the assessment of pleural effusion in patients with non-small-cell lung cancer.
Alkhawaldeh K; Biersack HJ; Henke A; Ezziddin S
Clin Nucl Med; 2011 Jun; 36(6):423-8. PubMed ID: 21552017
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
5. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L
Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256
[TBL] [Abstract][Full Text] [Related]
6. Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT.
Kasai T; Motoori K; Horikoshi T; Uchiyama K; Yasufuku K; Takiguchi Y; Takahashi F; Kuniyasu Y; Ito H
Eur J Radiol; 2010 Aug; 75(2):143-6. PubMed ID: 19446975
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
8. Incremental value of PET/CT Over CT for mediastinal nodal staging of non-small cell lung cancer: Comparison between patients with and without idiopathic pulmonary fibrosis.
Jeon TY; Lee KS; Yi CA; Chung MP; Kwon OJ; Kim BT; Shim YM
AJR Am J Roentgenol; 2010 Aug; 195(2):370-6. PubMed ID: 20651192
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.
Liu BJ; Dong JC; Xu CQ; Zuo CT; Le JJ; Guan YH; Zhao J; Wu JF; Duan XH; Cao YX
Chin Med J (Engl); 2009 Aug; 122(15):1749-54. PubMed ID: 19781319
[TBL] [Abstract][Full Text] [Related]
10. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
[TBL] [Abstract][Full Text] [Related]
11. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
[TBL] [Abstract][Full Text] [Related]
12. F-18 fluorodeoxyglucose PET/CT findings in active hiccups.
Yeatman CF; Minoshima S
Clin Nucl Med; 2009 Mar; 34(3):197-8. PubMed ID: 19352293
[TBL] [Abstract][Full Text] [Related]
13. Detection of prostatic glandular adenocarcinoma during staging of non-small-cell lung carcinoma with F-18 FDG PET.
Conrad GR; Sinha P; Absher K; Lee J
Clin Nucl Med; 2009 Feb; 34(2):79-81. PubMed ID: 19352256
[No Abstract] [Full Text] [Related]
14. A review of noninvasive staging of the mediastinum for non-small cell lung carcinoma.
McField D; Bauer T
Surg Oncol Clin N Am; 2011 Oct; 20(4):681-90. PubMed ID: 21986265
[TBL] [Abstract][Full Text] [Related]
15. Is fluorine 18 fluorodeoxyglucose positron emission tomography scanning a suitable diagnostic test for histologically active large-vessel vasculitis?
Bhattacharjee S; Yap K; Longano A; Powell A
J Clin Rheumatol; 2011 Jan; 17(1):31-4. PubMed ID: 21169851
[TBL] [Abstract][Full Text] [Related]
16. Teflon injection for vocal cord paralysis: false-positive finding on FDG PET-CT in a patient with non-small cell lung cancer.
Truong MT; Erasmus JJ; Macapinlac HA; Podoloff DA
AJR Am J Roentgenol; 2004 Jun; 182(6):1587-9. PubMed ID: 15150014
[No Abstract] [Full Text] [Related]
17. Primary mediastinal large B-cell lymphoma (thymic lymphoma) imaged with F-18 FDG PET-CT.
Makis W; Derbekyan V; Hickeson M
Clin Nucl Med; 2010 Jun; 35(6):421-4. PubMed ID: 20479590
[No Abstract] [Full Text] [Related]
18. Performance of
Laffon E; Marthan R
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):522-523. PubMed ID: 30377737
[No Abstract] [Full Text] [Related]
19. Prospective study of 18F-FDG PET in pediatric mediastinal lymphoma: a single center experience.
Edeline V; Bonardel G; Brisse H; Foehrenbach H; Pacquement H; Maszelin P; Gaillard JF; Michon J; Neuenschwander S
Leuk Lymphoma; 2007 Apr; 48(4):823-6. PubMed ID: 17454646
[No Abstract] [Full Text] [Related]
20. Mediastinal mapping with positron emission tomography/computed tomography.
Falay O; Kutlu CA
Ann Thorac Surg; 2008 Apr; 85(4):1457. PubMed ID: 18355557
[No Abstract] [Full Text] [Related]
[Next] [New Search]
